CalciMedica Inc (CALC) has a current Price-to-Book (P/B) ratio of -358.57. Compared to its 3-year average P/B ratio of -17.63, the current P/B ratio is approximately 1934.06% higher. Relative to its 5-year average P/B ratio of -17.63, the current P/B ratio is about 1934.06% higher. CalciMedica Inc (CALC) has a Forward Free Cash Flow (FCF) yield of approximately -21.95%. Compared to its 3-year average FCF yield of -72.58%, the current FCF yield is approximately -69.75% lower. Relative to its 5-year average FCF yield of -72.58%, the current FCF yield is about -69.75% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for CALC competitors is 0.71, providing a benchmark for relative valuation. CalciMedica Inc Corp (CALC.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of CALC increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of CALC in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is CALC currently overvalued or undervalued?

What is CalciMedica Inc (CALC) fair value?

CALC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of CalciMedica Inc (CALC) is between to according to relative valuation method.

How does CALC's valuation metrics compare to the industry average?

The average P/S ratio for CALC's competitors is 0.71, providing a benchmark for relative valuation. CalciMedica Inc Corp (CALC) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for CalciMedica Inc (CALC) as of Mar 03 2026?

As of Mar 03 2026, CalciMedica Inc (CALC) has a P/B ratio of -358.57. This indicates that the market values CALC at -358.57 times its book value.

What is the current FCF Yield for CalciMedica Inc (CALC) as of Mar 03 2026?

As of Mar 03 2026, CalciMedica Inc (CALC) has a FCF Yield of -21.95%. This means that for every dollar of CalciMedica Inc's market capitalization, the company generates -21.95 cents in free cash flow.

What is the current Forward P/E ratio for CalciMedica Inc (CALC) as of Mar 03 2026?

As of Mar 03 2026, CalciMedica Inc (CALC) has a Forward P/E ratio of -3.49. This means the market is willing to pay $-3.49 for every dollar of CalciMedica Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for CalciMedica Inc (CALC) as of Mar 03 2026?

As of Mar 03 2026, CalciMedica Inc (CALC) has a Forward P/S ratio of 0.00. This means the market is valuing CALC at $0.00 for every dollar of expected revenue over the next 12 months.

CALC Valuation